These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18925386)

  • 1. Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A.
    Inan S; Lee DY; Liu-Chen LY; Cowan A
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):263-70. PubMed ID: 18925386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A.
    Wang Y; Chen Y; Xu W; Lee DY; Ma Z; Rawls SM; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1073-83. PubMed ID: 18089845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys.
    Huskinson SL; Platt DM; Brasfield M; Follett ME; Prisinzano TE; Blough BE; Freeman KB
    Psychopharmacology (Berl); 2020 Jul; 237(7):2075-2087. PubMed ID: 32372348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
    Wang Y; Tang K; Inan S; Siebert D; Holzgrabe U; Lee DY; Huang P; Li JG; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2005 Jan; 312(1):220-30. PubMed ID: 15383632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nalfurafine, a G-Protein-Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics.
    Meariman JK; Sutphen JC; Gao J; Kapusta DR
    Hypertension; 2022 Feb; 79(2):379-390. PubMed ID: 34852633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.
    Liu JJ; Chiu YT; DiMattio KM; Chen C; Huang P; Gentile TA; Muschamp JW; Cowan A; Mann M; Liu-Chen LY
    Neuropsychopharmacology; 2019 Apr; 44(5):939-949. PubMed ID: 30082888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential structure of the κ opioid receptor agonist nalfurafine for binding to the κ receptor.
    Nagase H; Fujii H
    Curr Pharm Des; 2013; 19(42):7400-14. PubMed ID: 23448474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats.
    Baker LE; Panos JJ; Killinger BA; Peet MM; Bell LM; Haliw LA; Walker SL
    Psychopharmacology (Berl); 2009 Apr; 203(2):203-11. PubMed ID: 19153716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu and kappa opioid receptor agonists antagonize icilin-induced wet-dog shaking in rats.
    Werkheiser JL; Rawls SM; Cowan A
    Eur J Pharmacol; 2006 Oct; 547(1-3):101-5. PubMed ID: 16945367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential properties between TRK-820 and U-50,488H on the discriminative stimulus effects in rats.
    Mori T; Nomura M; Yoshizawa K; Nagase H; Narita M; Suzuki T
    Life Sci; 2004 Oct; 75(20):2473-82. PubMed ID: 15350822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice.
    Dunn A; Windisch K; Ben-Ezra A; Pikus P; Morochnik M; Erazo J; Reed B; Kreek MJ
    Psychopharmacology (Berl); 2020 Aug; 237(8):2405-2418. PubMed ID: 32435819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug design and synthesis of a novel kappa opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology.
    Nagase H; Watanabe A; Nemoto T; Yamaotsu N; Hayashida K; Nakajima M; Hasebe K; Nakao K; Mochizuki H; Hirono S; Fujii H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):121-4. PubMed ID: 19962305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through G
    Barnett ME; Knapp BI; Bidlack JM
    Mol Pharmacol; 2020 Oct; 98(4):462-474. PubMed ID: 32958572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.
    Jamshidi RJ; Jacobs BA; Sullivan LC; Chavera TA; Saylor RM; Prisinzano TE; Clarke WP; Berg KA
    J Pharmacol Exp Ther; 2015 Nov; 355(2):174-82. PubMed ID: 26297384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats.
    Zamarripa CA; Pareek T; Schrock HM; Prisinzano TE; Blough BE; Sufka KJ; Freeman KB
    Psychopharmacology (Berl); 2021 Dec; 238(12):3463-3476. PubMed ID: 34430992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
    Vaupel DB; Cone EJ; Johnson RE; Su TP
    J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
    Bian JS; Pei JM; Cheung CS; Zhang WM; Wong TM
    J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
    Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
    Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice.
    Tsuji M; Yamazaki M; Takeda H; Matsumiya T; Nagase H; Tseng LF; Narita M; Suzuki T
    Eur J Pharmacol; 2000 Apr; 394(1):91-5. PubMed ID: 10771039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalization of NMDA-receptor antagonists to the discriminative stimulus effects of kappa-opioid receptor agonists U-50,488H, but not TRK-820 in rats.
    Mori T; Nomura M; Yoshizawa K; Nagase H; Sawaguchi T; Narita M; Suzuki T
    J Pharmacol Sci; 2006 Feb; 100(2):157-61. PubMed ID: 16474203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.